Evidence map›Paper›PMID 31823221›Full record

ReviewJournal of cardiovascular translational research2020

The Role of Deubiquitinases in Vascular Diseases.

Biqing Wang, Wenbin Cai, Ding Ai, Xu Zhang, Liu Yao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The role of deubiquitinases in cardiac disease.Expert reviews in molecular medicine · 2024
    Review
  11. Deubiquitinases in cancer.Nature reviews. Cancer · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.International journal of molecular sciences · 2020
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Biqing WangKey Laboratory of Immune Microenvironment and Disease (Ministry of Education) and Department of Physiology and Pathophysiology Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, 300070, China.
Wenbin CaiKey Laboratory of Immune Microenvironment and Disease (Ministry of Education) and Department of Physiology and Pathophysiology Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, 300070, China.
Ding AiKey Laboratory of Immune Microenvironment and Disease (Ministry of Education) and Department of Physiology and Pathophysiology Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, 300070, China.
Xu ZhangKey Laboratory of Immune Microenvironment and Disease (Ministry of Education) and Department of Physiology and Pathophysiology Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, 300070, China. xuzhang@tmu.edu.cn.
Liu YaoKey Laboratory of Immune Microenvironment and Disease (Ministry of Education) and Department of Physiology and Pathophysiology Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, 300070, China. yaoliu@tmu.edu.cn.
Tianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deubiquitinases (DUBs) are a major component of the ubiquitin-proteasome system in eukaryotic cells; the system plays a crucial role in many biological processes, such as inflammation, oxidative stress, and cell apoptosis, which are important in vascular biology and pathology. DUBs have drawn significant attention in recent years, and their function is increasingly linked with vascular diseases. In this review, we summarize the indirect and direct evidence for the effects of DUBs on atherosclerosis, abdominal aortic aneurysm, angiogenesis, and hypertension, and point out pathways that could be pursued for investigating DUBs. Intervention in the function of DUBs in vascular diseases has potential therapeutic value.

Indexed as

AnimalsBlood VesselsDeubiquitinating EnzymesHumansLysineSignal TransductionUbiquitinationVascular DiseasesDeubiquitinating EnzymesLysineAbdominal Aortic AneurysmAngiogenesisAtherosclerosisDeubiquitinasesHypertension

Identifiers

PMID31823221
OpenAlexW2994292642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.